825 related articles for article (PubMed ID: 17095531)
1. Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats.
Akimoto Y; Hart GW; Wells L; Vosseller K; Yamamoto K; Munetomo E; Ohara-Imaizumi M; Nishiwaki C; Nagamatsu S; Hirano H; Kawakami H
Glycobiology; 2007 Feb; 17(2):127-40. PubMed ID: 17095531
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of O-GlcNAc-modified proteins and O-GlcNAc transferase in corneas of diabetic Goto-Kakizaki rats.
Akimoto Y; Kawakami H; Yamamoto K; Munetomo E; Hida T; Hirano H
Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3802-9. PubMed ID: 12939295
[TBL] [Abstract][Full Text] [Related]
3. The transcription factor PDX-1 is post-translationally modified by O-linked N-acetylglucosamine and this modification is correlated with its DNA binding activity and insulin secretion in min6 beta-cells.
Gao Y; Miyazaki J; Hart GW
Arch Biochem Biophys; 2003 Jul; 415(2):155-63. PubMed ID: 12831837
[TBL] [Abstract][Full Text] [Related]
4. Role of the O-GlcNAc modification on insulin resistance and endoplasmic reticulum stress in 3T3-L1 cells.
Sermikli BP; Aydogdu G; Yilmaz E
Mol Biol Rep; 2020 Aug; 47(8):5927-5942. PubMed ID: 32691273
[TBL] [Abstract][Full Text] [Related]
5. O-GlcNAc modification, insulin signaling and diabetic complications.
Issad T; Masson E; Pagesy P
Diabetes Metab; 2010 Dec; 36(6 Pt 1):423-35. PubMed ID: 21074472
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of mitochondrial FAD-linked glycerol-3-phosphate dehydrogenase does not correct glucose-stimulated insulin secretion from diabetic GK rat pancreatic islets.
Ueda K; Tanizawa Y; Ishihara H; Kizuki N; Ohta Y; Matsutani A; Oka Y
Diabetologia; 1998 Jun; 41(6):649-53. PubMed ID: 9662045
[TBL] [Abstract][Full Text] [Related]
7. O-GlcNAc modification affects the ATM-mediated DNA damage response.
Miura Y; Sakurai Y; Endo T
Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
[TBL] [Abstract][Full Text] [Related]
8. Exploring leukocyte O-GlcNAcylation as a novel diagnostic tool for the earlier detection of type 2 diabetes mellitus.
Springhorn C; Matsha TE; Erasmus RT; Essop MF
J Clin Endocrinol Metab; 2012 Dec; 97(12):4640-9. PubMed ID: 23066116
[TBL] [Abstract][Full Text] [Related]
9. Developmental regulation of protein O-GlcNAcylation, O-GlcNAc transferase, and O-GlcNAcase in mammalian brain.
Liu Y; Li X; Yu Y; Shi J; Liang Z; Run X; Li Y; Dai CL; Grundke-Iqbal I; Iqbal K; Liu F; Gong CX
PLoS One; 2012; 7(8):e43724. PubMed ID: 22928023
[TBL] [Abstract][Full Text] [Related]
10. Insulin secretion is stimulated by ethanol extract of Anemarrhena asphodeloides in isolated islet of healthy Wistar and diabetic Goto-Kakizaki Rats.
Hoa NK; Phan DV; Thuan ND; Ostenson CG
Exp Clin Endocrinol Diabetes; 2004 Oct; 112(9):520-5. PubMed ID: 15505760
[TBL] [Abstract][Full Text] [Related]
11. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.
Vosseller K; Wells L; Lane MD; Hart GW
Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5313-8. PubMed ID: 11959983
[TBL] [Abstract][Full Text] [Related]
12. O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress.
Butkinaree C; Park K; Hart GW
Biochim Biophys Acta; 2010 Feb; 1800(2):96-106. PubMed ID: 19647786
[TBL] [Abstract][Full Text] [Related]
13. O-GlcNAcylation under hypoxic conditions and its effects on the blood-retinal barrier in diabetic retinopathy.
Xu C; Liu G; Liu X; Wang F
Int J Mol Med; 2014 Mar; 33(3):624-32. PubMed ID: 24366041
[TBL] [Abstract][Full Text] [Related]
14. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
[TBL] [Abstract][Full Text] [Related]
15. New insights: A role for O-GlcNAcylation in diabetic complications.
Peterson SB; Hart GW
Crit Rev Biochem Mol Biol; 2016; 51(3):150-61. PubMed ID: 26806492
[TBL] [Abstract][Full Text] [Related]
16. O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells.
Goldberg H; Whiteside C; Fantus IG
Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E713-26. PubMed ID: 21712532
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a Functional O-Linked N-Acetylglucosamine (O-GlcNAc) System in the Thermophilic Bacterium Thermobaculum terrenum.
Ostrowski A; Gundogdu M; Ferenbach AT; Lebedev AA; van Aalten DM
J Biol Chem; 2015 Dec; 290(51):30291-305. PubMed ID: 26491011
[TBL] [Abstract][Full Text] [Related]
18.
Zambrana S; Lundqvist LCE; Mamani O; Catrina SB; Gonzales E; Östenson CG
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30037028
[No Abstract] [Full Text] [Related]
19. O-GlcNAc modification of nucleocytoplasmic proteins and diabetes.
Akimoto Y; Hart GW; Hirano H; Kawakami H
Med Mol Morphol; 2005 Jun; 38(2):84-91. PubMed ID: 15944815
[TBL] [Abstract][Full Text] [Related]
20. Role of O-linked N-acetylglucosamine modification in diabetic nephropathy.
Gellai R; Hodrea J; Lenart L; Hosszu A; Koszegi S; Balogh D; Ver A; Banki NF; Fulop N; Molnar A; Wagner L; Vannay A; Szabo AJ; Fekete A
Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1172-F1181. PubMed ID: 27029430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
